Concepedia

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

KT Kelsey, David Ross, R D Traver, DC Christiani, Z-F Zuo, M. R. Spitz, M Wang, Xilin Xu, B.K. Lee, BS Schwartz,

British Journal of Cancer · 1997 · 191 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States

Richard Elledge, Gary M. Clark, Gary C. Chamness et al. · JNCI Journal of the National Cancer Institute · 1994 · 417 citations

, , +13

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

R D Traver, T. Horikoshi, Kathleen D. Danenberg et al. · PubMed · 1992 · 317 citations

, , +13

Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9

Sara A. Fitzsimmons, Paul Workman, Michael R. Grever et al. · JNCI Journal of the National Cancer Institute · 1996 · 235 citations · Full text

, , +17

Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.

David Siegel, N W Gibson, Peter C. Preusch et al. · PubMed · 1990 · 225 citations

, , +15

Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.

Paul Workman · PubMed · 1994 · 124 citations

, , +14